期刊文献+

老年结直肠癌的治疗 被引量:4

Colorectal Treatment in Older Patients
下载PDF
导出
摘要 老年患者占结直肠癌患者的70%,因此老年人是结直肠癌的主要患病人群。为了提高结直肠癌治疗的总体疗效,我们应当特别关注老年性结直肠癌的治疗。以往,手术治疗和化疗的应用随着年龄的增高而明显减少。我们一直以为老年人手术和化疗的效果不令人满意。近期的研究改变了这一认识。证据表明辅助化疗和姑息性化疗对一般情况良好的老年人是有效而安全的。即使存在一些与年龄相关的基础疾病的老年结直肠癌患者仍然能从合理的治疗方案中获益。所以我们尚有许多工作需做,以提高老年性结直肠癌患者的疗效。腹腔镜下结肠癌根治术是对老年人安全有效的手术技术。我们期待随着经腔道的内窥镜手术技术的发展,将来会使老年性结直肠癌患者受益。 Colorectal cancer (CRC) is predominantly a disease of older persons, who make up more than 70% of CRC patients. To improve the outcomes of CRC, we should pay more attention to the treatment of older patients. As we know, both surgery and chemotherapy decline rapidly with age. The findings of recent studies have disputed the previously held belief that older patients do worse after bowel surgery or chemotherapy. Evidence supports the safety and efficacy of both adjuvant and palliative chemotherapy in fit old patients. Elderly CRC patients with age-related comorbidity can still benefit from optimal strategies.Therefore,we still have a lot of work to do to improve the overall survival and time to tumor recurrence of elderly CRC patients. Laparoscopic colonic resection is a safe and effective surgical technique in elderly patients. We look forward to the development of Natural Orifice Transluminal Endoscopic Surgery (NOTES),which will benefit the elderly CRC patients in future.
作者 蒋蔚茹 刘杰
出处 《医学与哲学(B)》 2010年第4期13-15,共3页 Medicine & Philosophy(B)
关键词 结直肠癌 老年 治疗 化疗 colorectal cancer, elderly patients, treatment, ehemotheray
  • 相关文献

参考文献13

  • 1Richard M G, Neal J M, Josep Tabernero, et al. Accomplishments in 2008 in the treatment of advanced metastatic colorectal cancer [J]. Gastrointest Cancer, 2009, 3(suppl 2):S23-S27.
  • 2Hanna K S, Richard M G. Colorectal cancer treatment in older patients[J]. Gastrointestinal cancer research, 2007, 1 : 248- 253.
  • 3British Colorectal Collaborative Group. Surgery for eolorectal cancer in elderly patients: a systematic review[J]. Lancet, 2000,356 (9234) : 968- 974.
  • 4MeCardle C S, Hole D J. Outcome following surgery for colorectal cancer[J]. Br Med Bull, 2002,64:119-125.
  • 5Lacy A M, Garcia--Valdecasas J C, Delgado S,et al. Laparoscopy -assisted colectomy versus colectomy for treatment of non-metastatic colon cancer: a randomized trial[J]. Lancet, 2002,359:2224-2229.
  • 6Andre T, Boni C, Navarro M, et al. Improved overall survival with oxalipatin, fluorouracil, and leucovorin as adjuvant treatment in stage Ⅱ or Ⅲ colon cancer in the MOSAIC trial[J]. J Clin, 2009, 27: 3109-3116.
  • 7Twelves C. Capecitabine as adjuvant treatment for stage Ⅲ colon cancer[J]. N Engl J Med, 2005,352: 2696-2704.
  • 8Schrag D, Cramer L D,Bach P B, et al. Age and adjuvant chemotherapy use after surgery for stage Ⅲ colon cancer[J]. J Natl Cancer Inst, 2001,93: 850-857.
  • 9Daniel J S, Richard M G, Stacy D J, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients [J]. N Engl Med,2001, 345(15):1091-1097.
  • 10Folprecht G, Seymour M T, Saltz L, et al. Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials[J]. J Clin Oncol, 2008,26: 1443-1451.

二级参考文献1

共引文献4

同被引文献26

  • 1Xuan Zhu,Shuang-Hong Zhang,Kun-He Zhang,Bi-Ming Li,Jiang Chen.Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-n and telomerase in the early diagnosis of esophageal carcinoma[J].World Journal of Gastroenterology,2005,11(39):6090-6095. 被引量:9
  • 2左明,刘宝善,徐琳,燕锦,刘超.结直肠癌术后早期应用FOLFOX方案辅助化疗的临床评价[J].中国肿瘤,2007,16(3):204-207. 被引量:6
  • 3Richard M G,Neal J M,Josep Tabernero,et al.Accomplishments in 2008 in the treatment of advanced metastatic colorectal cancer[J].Gastrointest Cancer,2009,3(suppl 2):S23-S27.
  • 4Hanna K S,Richard M G.Colorectal cancer treatment in older patients[J].Gastrointestinal cancer research,2007,1:248-253.
  • 5Underhill C,Goldstein D,Gorbounova VA,et al.A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer[J].Oncology.2007,73(1-2):9-20.
  • 6Atkins JN,Jacobs SA,Wieand HS,et al.Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer:a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program[J].Clin Colorectal Cancer.2005 Sep,5(3):181-187.
  • 7John W,Picus J,Blanke CD,et al.Activity of multitargeted antifolate (pemetrexed disodium,LY231514) in patients with advanced colorectal carcinoma:results from a phase II study[J].Cancer.2000 Apr 15;88(8):1807-1813.
  • 8Hochster H,Kettner E,Kroning H,et al.Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancer[J].Clin Colorectal Cancer.2005 Nov;5(4):257-562.
  • 9Souglakos J,Androulakis N,Syrigos K,et al.FOLFOXIRI(folinic acid,5-fluorouracil,oxaliplatin and irinotecan) VS FOLFIRI (foiinic acid,5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC):a multicentre andomised phase Ⅲtrial from the Hellenic Oncology Research Group (HORG)[J].Br J Cancer,2006,94 (6):798-805.
  • 10VareyAH,Rennel ES,Qiu Y,et al.VEGF 165 b,an antiangiogenic VEGF2A isoform,binds and inhibits bevacizumab treatment in experimental colorectal carcinoma:balance of pro-and antiangiogenic VEGF2A isoforms has implications for therapy[J].BrJ Cancer,2008,98:1366-1379.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部